Megavog MF 0.3/500 mg Tablet (10 Tab)

Medicine Information

About Megavog MF 0.3/500 mg tablet:

Megavog MF 0.3/500 mg tablet is a combination of two anti-diabetic medications, used to treat type 2 diabetes mellitus.

Each uncoated bi-layer Megavog MF 0.3/500 mg tablet contains Metformin Hydrochloride 500 mg (As sustained-release form), Voglibose 0.3 mg and Excipients q.s.

Metformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilization.

Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with type 2 diabetes mellitus.

Use of Megavog MF 0.3/500 mg tablet:

Megavog MF 0.3/500 mg tablet is prescribed for the treatment of patients with type 2 diabetes mellitus. It helps control high blood glucose levels.

Usage Direction of Megavog MF 0.3/500 mg tablet:

• Megavog MF 0.3/500 mg tablet is intended for oral use only in a dose and direction as advised by the physician.
• Megavog MF 0.3/500 mg tablet is taken whole with the help of water.
• Do not crush, chew, or break the tablet.
• Do not skip or stop the medicine without physician's advice.
• Do not consume more than the prescribed quantity.

Precaution & Related Information of Megavog MF 0.3/500 mg tablet:

• It is dangerous to take this preparation except under medical supervision.
• If allergic to this medicine inform the physician immediately.
• If find any other complication inform the physician immediately.
• Consult with the physician during pregnancy & lactation.
• Keep out of reach of children.

Storage condition of Megavog MF 0.3/500 mg Tablet:

Store below 30ºC. Protect from light & moisture.